Merck discontinues Phase 3 KeyVibe-010 trial
The trial was discontinued after results showed that the coformulation of vibostolimab and pembrolizumab for treatment of resected…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.